Home › Eli Lilly, Incyte drug fares well in late-stage research
 

Keywords :   


Eli Lilly, Incyte drug fares well in late-stage research

2015-09-29 16:11:28| Biotech - Topix.net

A potential rheumatoid arthritis treatment from Eli Lilly and Incyte fared better than another drug in late-stage testing, and the drugmakers are moving closer to seeking regulatory approval to sell it. Lilly said Tuesday that early results from a study that enrolled around 600 patients showed that its oral medication, baricitinib, proved superior to the established treatment methotrexate.

Tags: research drug eli lilly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09AWA releases Glue-Applied Label Market Report 2024
23.09Hurricane John Graphics
23.09Hurricane John Forecast Discussion Number 5
23.09Hurricane John Wind Speed Probabilities Number 5
23.09Eastern North Pacific Tropical Weather Outlook
23.09Hurricane John Forecast Advisory Number 5
23.09Hurricane John Public Advisory Number 5
23.09Potential Tropical Cyclone Nine Public Advisory Number 1A
More »